Cargando…
Maximizing response to intratumoral immunotherapy in mice by tuning local retention
Direct injection of therapies into tumors has emerged as an administration route capable of achieving high local drug exposure and strong anti-tumor response. A diverse array of immune agonists ranging in size and target are under development as local immunotherapies. However, due to the relatively...
Autores principales: | Momin, Noor, Palmeri, Joseph R., Lutz, Emi A., Jailkhani, Noor, Mak, Howard, Tabet, Anthony, Chinn, Magnolia M., Kang, Byong H., Spanoudaki, Virginia, Hynes, Richard O., Wittrup, K. Dane |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8748612/ https://www.ncbi.nlm.nih.gov/pubmed/35013154 http://dx.doi.org/10.1038/s41467-021-27390-6 |
Ejemplares similares
-
Intratumoral nanobody–IL-2 fusions that bind the tumor extracellular matrix suppress solid tumor growth in mice
por: Lutz, Emi A, et al.
Publicado: (2022) -
Alum-anchored intratumoral retention improves the tolerability and antitumor efficacy of type I interferon therapies
por: Lutz, Emi A., et al.
Publicado: (2022) -
Tregs constrain CD8(+) T cell priming required for curative intratumorally anchored anti-4-1BB immunotherapy
por: Palmeri, Joseph R., et al.
Publicado: (2023) -
Immunotherapy-induced antibodies to endogenous retroviral envelope glycoprotein confer tumor protection in mice
por: Kang, Byong H., et al.
Publicado: (2021) -
An affinity threshold for maximum efficacy in anti-PD-1 immunotherapy
por: Cowles, Sarah C., et al.
Publicado: (2022)